B3GNT8

B3GNT8 is a Golgi-type beta-1,3-N-acetylglucosaminyltransferase that builds poly-N-acetyllactosamine chains on complex N-glycans, acting preferentially on tetraantennary and 2,6-branched structures (PMID:15620693, PMID:15917431). Its defining mechanistic feature is non-canonical: rather than functioning chiefly as a stand-alone catalyst, B3GNT8 forms a heterocomplex with beta3Gn-T2 and dramatically enhances beta3Gn-T2 activity, raising Vmax/Km roughly 9-fold over beta3Gn-T2 alone (PMID:15917431). Reciprocal catalytic-dead mutagenesis established that a DXD-inactive B3GNT8 still activates intact beta3Gn-T2, whereas inactive beta3Gn-T2 is not activated, demonstrating that B3GNT8 drives poly-LacNAc biosynthesis primarily through a scaffolding/activating role on its partner enzyme (PMID:18826941). B3GNT8 transcription is directly activated by c-jun, which binds the B3GNT8 promoter and increases poly-LacNAc glycosylation in gastric cancer cells (PMID:27459970), and B3GNT8 expression modulates the MMP-2/TIMP-2 balance and Matrigel invasion in these cells (PMID:20963502). In vivo, B3gnt8 knockout mice are hypersusceptible to DSS-induced colitis with impaired tight-junction integrity, reduced Paneth cells and lysozyme, and disrupted autophagy-lysosomal function linked to reduced LAMP1/2 glycosylation and the ATG16L1-ATG12-ATG5 pathway, indicating a role in intestinal epithelial homeostasis (PMID:41380967).

1. 2005 High

   Establishing that B3GNT8 is a glycosyltransferase answered whether it could extend N-glycans, defining it as a beta-1,3-GlcNAc transferase that initiates poly-N-acetyllactosamine synthesis on branched N-glycans.

   Evidence In vitro enzymatic assay plus cDNA transfection in HCT15 cells with lectin (LEA, PHA-L4) flow cytometry

   PMID:15620693

   Open questions at the time

   • Glycan branch preference not yet resolved
   • Endogenous physiological substrates not identified
   • No in vivo context
2. 2005 High

   Substrate profiling and gel filtration answered how B3GNT8 contributes to poly-LacNAc synthesis, revealing both 2,6-branch specificity and the surprising formation of an activating heterocomplex with beta3Gn-T2.

   Evidence Recombinant soluble enzymes from Pichia pastoris, defined-substrate kinetics, and Sephacryl S-300 gel filtration

   PMID:15917431

   Open questions at the time

   • Structural basis of the heterocomplex unknown
   • Stoichiometry of the ~110-210 kDa complex not defined
   • Mechanism of catalytic enhancement not established
3. 2008 High

   Catalytic-dead epistasis answered whether B3GNT8's effect is enzymatic or scaffolding, showing it activates beta3Gn-T2 through complex formation rather than its own catalysis.

   Evidence Co-IP from co-transfected COS-7 cells, DXD active-site mutagenesis with activity measurement, and overexpression in HL-60 cells with lectin detection

   PMID:18826941

   Open questions at the time

   • Interaction interface and structural mechanism unresolved
   • Whether B3GNT8 retains any independent catalytic role in vivo unclear
   • Regulation of complex assembly unknown
4. 2010 Medium

   Loss- and gain-of-function in gastric cancer cells addressed a cellular consequence of B3GNT8, linking it to MMP-2/TIMP-2 balance and invasive behavior.

   Evidence siRNA knockdown and overexpression in AGS cells with RT-PCR, western blot, gelatin zymography, and Matrigel invasion assay

   PMID:20963502

   Open questions at the time

   • No direct mechanistic link between glycosyltransferase activity and MMP-2 regulation established
   • Single lab, single cell line
   • Glycoprotein substrates mediating the effect not identified
5. 2016 Medium

   Promoter analysis answered how B3GNT8 expression is controlled in cancer cells, identifying c-jun as a direct transcriptional activator that drives poly-LacNAc glycosylation.

   Evidence Luciferase reporter assay, ChIP, RT-PCR/western blot, and LEA lectin detection in SGC-7901 cells

   PMID:27459970

   Open questions at the time

   • Upstream signals controlling c-jun in this context not defined
   • Direct link from CD147 glycosylation to phenotype not fully established
   • Single-lab evidence
6. 2017 Low

   A recombinant channel assay tested whether B3GNT8 glycosylation affects ion channel function, indicating a negative regulatory effect on Cav3.2 T-type calcium channels.

   Evidence Recombinant Cav3.2 co-expressed with glycan-processing enzymes and electrophysiological characterization

   PMID:32233724

   Open questions at the time

   • Single functional readout without mutagenesis or glycosylation-site mapping
   • B3GNT8-specific mechanism not isolated
   • No physiological validation
7. 2025 Medium

   A knockout mouse addressed the in vivo physiological role of B3GNT8, demonstrating its requirement for intestinal epithelial homeostasis and Paneth cell autophagy-lysosomal function.

   Evidence B3gnt8 knockout mice with DSS-induced colitis; histology, western blot, immunofluorescence for tight junctions, mucin, LAMP1/2; Paneth cell and microbiota profiling

   PMID:41380967

   Open questions at the time

   • Link between glycosylation and the ATG16L1-ATG12-ATG5 pathway is partially inferred
   • Direct demonstration that LAMP1/2 glycosylation drives lysosomal stability not shown
   • Single lab, single study

• How B3GNT8-dependent poly-LacNAc synthesis on specific glycoproteins mechanistically couples to downstream phenotypes (invasion, channel regulation, autophagy) remains unresolved.
• No structural model of the B3GNT8-beta3Gn-T2 complex
• Direct causal chain from glycan modification to cellular phenotype not established for any system
• Physiological substrate repertoire incompletely defined